Reaction
Spinal Cord Disorder reporting signals
As of the last recalculation, Spinal Cord Disorder appears in 1,630 FAERS reports alongside 23 co-occurring drug terms. The strongest observed disproportionality signal is DAPTOMYCIN (PRR 19.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Daptomycin | 14 | 19.5 | 19.6 |
| Bupivacaine | 11 | 15.1 | 15.1 |
| Busulfan | 15 | 12.3 | 12.3 |
| Blinatumomab | 9 | 11.1 | 11.1 |
| Valsartan And Hydrochlorothiazide | 10 | 9.5 | 9.5 |
| Heparin Sodium | 10 | 9.3 | 9.3 |
| Goserelin | 9 | 8.6 | 8.6 |
| Cytarabine | 35 | 7.6 | 7.6 |
| Insulin Glulisine | 6 | 7.6 | 7.6 |
| Brivaracetam | 5 | 7.1 | 7.1 |
| Ribociclib | 17 | 6.9 | 6.9 |
| Fingolimod Hcl | 41 | 6.2 | 6.2 |
| Linezolid | 14 | 6.0 | 6.1 |
| Lutetium Lu 177 Vipivotide Tetraxetan | 5 | 4.9 | 4.9 |
| Interferon Beta-1A | 70 | 4.8 | 4.8 |
| Ravulizumab | 5 | 4.7 | 4.7 |
| Teriflunomide | 16 | 4.6 | 4.6 |
| Pseudoephedrine Hydrochloride | 3 | 3.7 | 3.7 |
| Glatiramer Acetate | 17 | 3.7 | 3.7 |
| Pseudoephedrine Hcl | 3 | 3.5 | 3.5 |
| Oxymorphone Hydrochloride | 3 | 3.3 | 3.3 |
| Ixazomib | 7 | 3.1 | 3.1 |
| Palivizumab | 3 | 2.5 | 2.5 |